Clinical Trials Logo

Asbestos Exposure clinical trials

View clinical trials related to Asbestos Exposure.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04106973 Terminated - Clinical trials for Pleural Mesothelioma

Mesothelioma Early Detection by VOCs

MED-VOC
Start date: June 5, 2019
Phase:
Study type: Observational

This is a two phase study, The first phase (phase 1) will identify potential biomarkers among asbestos exposed individuals with pleural mesothelioma. The second phase (phase 2), is a double blinded case-matched controlled study to determine the predictive capability, sensitivity, and specificity of these biomarkers in detecting early stage pleural mesothelioma. Biomarkers in the form of volatile organic compounds (VOC) in exhaled breath samples from subjects with either pleural mesothelioma or pleural plaques, will be evaluated. A biomarker present in serum will also be concurrently evaluated in the same cohort. The soluble serum biomarker mesothelin related peptides (SMRP), which has been posited as a biomarker for mesothelioma, will be analyzed for its relationship to the breath VOC profile.